News and Trends 23 Feb 2018
Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany
Update (23/02/2018): Merck Sharp & Dohme (MSD), licensee of AiCuris, has launched letermovir in Germany under the trade name Prevymis. The…
AiCuris
- Latest Posts
Best in Biotech 18 Dec 2017
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread some Christmas cheer with the…
News and Trends 13 Nov 2017
World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance
This week marks the WHO's World Antibiotic Awareness Week. We had a look at some of the best work being done…
News and Trends 1 Aug 2017
Potential Herpes Cure from Germany Fast-Tracked for Patients with Weak Immune Systems
AiCuris' Pritelivir has now secured FDA endorsement in the form of a Fast Track Designation in immuno-compromised patients. Based in…
ADVERTISEMENT
In Depth 9 May 2017
Rise of the Superbugs: How is Biotech Fighting Antibiotic Resistance?
Fewer antibiotics are produced as development costs rise. We reached out to a few companies addressing the serious issue of…
News and Trends 17 Jan 2017
This Herpes Cure is Proving to Work Better than its Predecessors
AiCuris' candidate pritelivir has shown to perform better than current standard antiviral treatments against genital herpes in Phase II trials.…
News and Trends 4 Jan 2017
Cold Sore Cure Company enters the Antibiotic Resistance fight
AiCuris is developing a new antibiotic that might bring hope for patients in which all options to fight infections have…
News and Trends 20 Oct 2016
German Record-deal Antiviral drug Succeeds in Phase III
AiCuris' Letermovir succeeds in Phase III after being licensed to MSD in a record €442.5M deal. It acts on a novel CMV target to treat bone…
News and Trends 9 May 2016
Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure
Update (09/05/2017): AiCuris has started a Phase II trial, PRIOH-1, with the oral version of its herpes cure pritelivir. Update…
News and Trends 15 Feb 2016
Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO
AiCuris is a Biotech company based on the Bayer Life Sciences park in Wuppertal (Germany). It is working on new…